USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

TTABVUE. Trademark Trial and Appeal Board Inquiry System

v2.5.0

Summary

Query: Party Name contains all words: NOVARTIS AG
Number of results: 476+
Results are in reverse chronological order

Proceeding
Filing Date

Defendant(s),
Property(ies)

Plaintiff(s),
Property(ies)

92055134
02/06/2012

Apex Bioscience, Inc.
Mark: APEX S#:74480192 R#:1998563

Novartis AG
Mark: APEX-IHN S#:85172907

91203570
01/30/2012

Leo Pharma A/S
Mark: LORSIMA S#:85261150

Novartis AG
Mark: LORYNA S#:77850568

85388285
01/27/2012

Mylan Pharmaceuticals, Inc.
Mark: OYALAS S#:85388285

Novartis AG

85417711
01/19/2012

Novartis AG
Mark: REVELLA S#:85417711

Forest Laboratories, Inc.

85376081
01/06/2012

Epitopoietic Research Corporation
Mark: GLIOVAC S#:85376081

Novartis AG

92054986
12/29/2011

Santen Pharmaceutical Co. Ltd.
Mark: TAFLOTAN S#:79016945 R#:3194510

Novartis AG
Mark: TRAVATAN S#:75499958 R#:2496583
Mark: TRAVATAN Z S#:78864112 R#:3321490

85361690
12/27/2011

SmithKline Beecham Limited
Mark: ZYNIPRO S#:85361690

Novartis AG

91203115
12/22/2011

Durect Corporation
Mark: CLOUD S#:85229178

Novartis AG
Mark: CLOUDHALER S#:77709347

91203110
12/22/2011

Medox Healthcare, Inc.
Mark: LOXAIR S#:85358996

Novartis AG
Mark: XOLAIR S#:78296612 R#:3086141
Mark: XOLAIR S#:78269788 R#:2998978
Mark: XOLAIR S#:78109911 R#:2707154
Mark: XOLAIR S#:78073589 R#:2678068

85395080
12/22/2011

Novartis AG
Mark: REJENA S#:85395080

Glaxo Group Limited

79094917
12/20/2011

DEFIANTE FARMACÊUTICA, S.A.
Mark: ONVERTIS S#:79094917

Novartis AG

85368753
12/07/2011

Novartis AG
Mark: DEVENDA S#:85368753

MERZ PHARMA GmbH & CO. KGaA

85350365
12/06/2011

Novartis AG
Mark: AQUAZOLVES S#:85350365

Fagron

79102567
12/05/2011

NOVARTIS AG
Mark: POMRELT S#:79102567

POMWonderful LLC

85357081
12/05/2011

Lam, Daren
Mark: QUANNEX S#:85357081

Vivus, Inc.
Novartis AG

85302629
11/23/2011

Synedgen, Inc.
Mark: CATASYN S#:85302629

Novartis AG

85341045
11/18/2011

Bayer Aktiengesellschaft
Mark: LUCENLO S#:85341045

GENENTECH, INC.
Novartis AG

85201011
11/15/2011

Upsher-Smith Laboratories, Inc.
Mark: BEXLIDO S#:85201011

Novartis AG

85338823
11/10/2011

Glaxo Group Limited
Mark: TEXPRA S#:85338823

Novartis AG

85300593
11/10/2011

ZO Skin Health, Inc.
Mark: ZO RX S#:85300593

Novartis AG

85338621
11/04/2011

Biorest Ltd.
Mark: BIOREST S#:85338621

Novartis AG

85376455
10/19/2011

Arena Pharmaceuticals GmbH
Mark: SYATI S#:85376455

Novartis AG

85221043
10/13/2011

Novartis AG
Mark: GO S#:85221043

The Cleveland Clinic Foundation

85221048
10/13/2011

Novartis AG
Mark: GO PROGRAM S#:85221048

The Cleveland Clinic Foundation

85221071
10/13/2011

Novartis AG
Mark: GO S#:85221071

The Cleveland Clinic Foundation